A retrospective, real-world study evaluating efficacy of mepolizumab in patients with severe asthma and associated comorbidities
Latest Information Update: 06 Sep 2023
At a glance
- Drugs Mepolizumab (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 03 Jun 2021 New trial record
- 23 May 2021 Results published in the Annals of Allergy, Asthma and Immunology